US FDA’s Speed Of Work Under Trump Quietly Raising Industry Concerns

 
• By Sarah Karlin-Smith
  
yellow sign reads slow lane ahead with arrow pointing to right.
Industry stakeholders are starting to quietly complain that the FDA's pace of work is slowing. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Product Reviews